Physicians' Academy for Cardiovascular Education

Managing inflammation in CVD: Debating the rationale for interventions

Sep. 1, 2014

Presentations and video recordings will be available soon



EBAC accredited educational programme held on September 1, 2014
 

Educational objectives

  • Review the current evidence supporting the inflammatory hypotheses of atherothrombosis
  • Review the epidemiology of hsCRP in risk stratification in CV disease
  • Discuss the rationale for lowering vascular events by inhibition of inflammation
  • Discuss the mechanism of blocking the pro-inflammatory cytokine interleukin -1β (IL-1β) with a monoclonal antihuman antibody
  • Discuss the potential of current and future strategies targeting inflammation in cardiovascular disease
  • Outline current ongoing clinical development programs aimed to address the inflammation hypothesis in cardiovascular disease

Introduction
Wolfgang Koenig, University of Ulm Medical Center, Ulm, Germany
Peter Libby, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
 
Agenda
Inflammation in atherosclerosis & ACS: A perspective from vascular biology
Peter Libby, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
 
The role of inflammation in ACS: A clinical perspective
Filippo Crea, Catholic University of the Sacred Heart, Rome, Italy
 
An update on trials targeting inflammation: Assessing new anti-inflammatory agents
Paul Ridker, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
 
13:35 – 13:45: Q&A & summary
Wolfgang Koenig, Peter Libby

 

 

CME Accreditation

This programme is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit(s). Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards the European Accreditation for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS


Financial support

Supported by unrestricted educational grants from Novartis   

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.